Beta Bionics held its 2026 Annual Meeting on May 21, 2026, with stockholders voting to elect two directors and ratify Ernst & Young as independent auditor.
Key takeaways
Stockholders elected Sean D. Carney and Christy Jones as Class I directors for terms expiring in 2029.
Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal 2026.